Syngoi Technologies

This would be the result if synthetic DNA technology started to be applied ✅ Take a look! ⬇️ #Biotechwebinar #Biotech #mRNA #Innovation #Health

🔬🌟 Leading the Future of mRNA 🌟🔬 mRNA biotech companies are revolutionizing medicine beyond COVID-19 vaccines. From gene therapies to personalized cancer treatments, these firms are at the forefront of innovation. Check out the full article from Labiotech to see which companies are making a significant impact in this field. Read more : https://lnkd.in/diemYMQC #Biotech #mRNA #Innovation #Health

Which are the problems to be solved to accelerate mRNA production?🧬 Take a look! ⬇️ #Biotechwebinar #Biotech #mRNA #Innovation #Health

The Elephant Endotheliotropic Herpesvirus (EEHV) is deadly for young Asian elephants. The Houston Zoo has administered the first mRNA vaccine against EEHV, developed in collaboration with Baylor College of Medicine. This groundbreaking vaccine triggers an immune response to combat the virus, offering new hope for protecting young elephants. If successful, the vaccine could be used in other zoos and potentially in wild populations. Read more here https://lnkd.in/dR4J2h2W

Merck Group highlights collaboration with Afrigen Biologics to develop local vaccine manufacturing capabilities in Africa, with the goal of increasing the availability of vaccines against diseases such as COVID-19 in the region. This effort aims to strengthen healthcare infrastructure and foster self-sufficiency in biologics production on the African continent. Read more here: https://lnkd.in/d2se4Pew

🌐 During the mRNA Process Development and Manufacturing Summit in Boston, we presented our collaboration with CEPI (Coalition for Epidemic Preparedness Innovations) and Afrigen Biologics (Pty) Ltd. This partnership aims to develop an mRNA vaccine using Syngoi’s oDNA technology, reducing production time to just 45 days. #Syngoi #BostonSummit #mRNA

🧬 Yesterday we had the pleasure of arriving in Boston and start the meetings. Today, the mRNA Process Development and Manufacturing Summit kicked off with Julen's presentation at 11:30 am. If you're attending, don't forget to visit us at Booth #14 🤗 Over the next days, we look forward to building new synergies and making great strides as we continue to push boundaries and drive growth. #Syngoi #BostonSummit #mRNA

The Indian government is considering vaccinating older women against cervical cancer using innovative mRNA vaccine technology🌐👩⚕️. Read more here: https://lnkd.in/dGwpnffz

🚀 See you in Boston! 🚀 At the mRNA Process and Manufacturing Summit 2024, 17-19 September, Julen Oyarzabal, Chief Scientific Officer at Syngoi, will present on 18 September at 11:30h on ‘Optimized Synthetic DNA to speed up mRNA delivery’. We will discuss how to accelerate turnaround times, improve mRNA quality and optimise the production process. 🔗 Don't miss it! Register here https://lnkd.in/eE6fh_kY #mRNA #Biotech #SyngoiInBoston

📅 See you on 19 September in Boston! We are excited to participate in the mRNA Process Development and Manufacturing Summit. If you want to find out how we are revolutionising mRNA manufacturing, don't miss it. 🔗 Register now! https://lnkd.in/eE6fh_kY #Biotechnology #Syngoi #mRNA #Innovation #Boston2024 #MRNAManufacturing #SummitBiotech #BiotechnologyProcesses